Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life of GERD in Patients With Erosive Gastroesophageal Reflux Disease.

NCT00545883 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00545883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00545883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life of GERD in Patients With Erosive Gastroesophageal Reflux Disease.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
March 31, 2008
Enrollment
2,001 (actual)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

gerd